/ clinical trails
/ Market Analysis
Why Did Lyra Therapeutics’ Stock Rocket Past 440% in Premarket Today
Lyra Therapeutics stock surged in premarket trading after announcing positive Phase 3 trial results for a key treatment.
June 02, 2025